Download the 2026 Obesity & Weight Loss Drug Development Summit Event Guide

The 4th Obesity & Weight Loss Drug Development Summit is your essential industry platform focused on bridging the gap from novel mechanisms to human impact, driving preclinical and clinical advantage in an increasingly competitive obesity drug development landscape.

Newly added: What's New for 2026 - Find out why 2026 is a milestone year, and how the Summit has been re-engineered to meet the rapidly-evolving landscape...

ee7 brochure image

Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

Attending Companies Include

Canary Global
cirius
eleven therapeutics
NYU

Speakers Include

Dan Oieru

Medical Director, Lead Cardiovascular Renal Metabolics, Product Development Roche Genentech
Roche

Chien Li

Associate Director
Novo Nordisk

Kenneth Attie

Vice President – Clinical Cardiometabolic Research
Eli Lilly & Co.

Ann Belien

Founder & Chief Executive Officer
Rejuvenate Biomed